This customizable document, Investigational Drug Information Record Form, is taken from MCN Healthcare’s Behavioral Health Partial Hospitalization Program Policy and Procedure Manual. For more than 20 years, MCN has been the health care industry’s leading provider of policy and procedure templates, forms, competencies and other compliance tools.

MCN provides more than 80 health care specific policy and procedure manuals for Acute Care Hospitals, Ambulatory Care, Behavioral Health, Home Health, Physician Practice, and Long Term Care. MCN’s policy and procedure manuals focus on the latest healthcare "hot topic" issues related to patient safety and prevention of medical healthcare errors.

Here is some sample content from Investigational Drug Information Record Form:

	INVESTIGATIONAL DRUG INFORMATION RECORD Generic Name: Code Name/Number: Therapeutic Class: Pharmacological Properties: Common Side Effects: Overdose Symptoms: Antidote: Special Precautions: Restricted Use Age, Sex, etc.: Physical Properties: Available Strengths: Expiration Date: Dosage Range: LD50 if known: Principle Investigator: Address: Participating Physicians: References: Medical Staff Approval date: Chief Executive Officer's Approval date: Note: The Pharmacy will be responsible for storage and distribution of all investigational drugs. Reference #1019 Partial...
Second excerpt:
	...Approval date: Chief Executive Officer's Approval date: Note: The Pharmacy will be responsible for storage and distribution of all investigational drugs. Reference #1019 Partial...